-
-
-
-
-
-
-
Can-Fite Announces $3.0 Million Registered Direct Offering of American Depositary Shares
-
-
-
-
-
-
-
Can-Fite to Present its Phase IIb NASH Drug Candidate Namodenoson at Upcoming Conference
-
-
-
-
-
-
-
Can-Fite to Present its NASH Program in Fireside Chat at the H.C. Wainwright 6th Annual Israel Conference on November 12, 2020
-
-
-
-
-
-
-
Can-Fite BioPharma Announces Pricing of $5 Million Public Offering
-
-
-
-
-
-
-
Can-Fite BioPharma (CANF) Announces Proposed Registered Direct ADS Offering
-
-
-
-
-
-
-
Can-Fite BioPharma Announces $5 Million Registered Direct Offering
-
-
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

